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ORIGINAL ARTICLE
A comprehensive motion analysis – consequences for high precision image-
guided radiotherapy of esophageal cancer patients
Catharina T. G. Roosa, Zohra Faizb, Sabine Vissera, Margriet Dietersa, Hans Paul van der Laana,
Lydia A. den Ottera, John T. M. Plukkerb, Johannes A. Langendijka , Antje-Christin Knopfa, Christina T. Muijsa
and Nanna M. Sijtsemaa
aDepartment of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands;
bDepartment of Surgical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
ABSTRACT
Background and purpose: When treating patients for esophageal cancer (EC) with photon or proton
radiotherapy (RT), breathing motion of the target and neighboring organs may result in deviations
from the planned dose distribution. The aim of this study was to evaluate the magnitude and dosi-
metric impact of breathing motion. Results were based on comparing weekly 4D computed tomog-
raphy (4D CT) scans with the planning CT, using the diaphragm as an anatomical landmark for EC.
Material and methods: A total of 20 EC patients were included in this study. Diaphragm breathing
amplitudes and off-sets (changes in position with respect to the planning CT) were determined from
delineated left diaphragm structures in weekly 4D CT-scans. The potential dosimetric impact of respira-
tory motion was shown in several example patients for photon and proton radiotherapy.
Results: Variation in diaphragm amplitudes were relatively small and ranged from 0 to 0.8 cm.
However, the measured off-sets were larger, ranging from 2.1 to 1.9 cm. Of the 70 repeat CT-scans,
the off-set exceeded the ITV-PTV margin of 0.8 cm during expiration in 4 CT-scans (5.7%) and during
inspiration in 13 CT-scans (18.6%). The dosimetric validation revealed under- and overdosages in the
VMAT and IMPT plans.
Conclusions: Despite relatively constant breathing amplitudes, the variation in the diaphragm position
(off-set), and consequently tumor position, was clinically relevant. These motion effects may result in
either treatments that miss the target volume, or dose deviations in the form of highly localized over-
or underdosed regions.
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Radiotherapy plays a pivotal role in the curative treatment of
esophageal cancer (EC). Treatment is delivered either as neo-
adjuvant chemotherapy (followed by surgery), or as definitive
chemoradiotherapy [1]. Radiotherapy for EC is challenging
due to vital organs (e.g., heart and lungs) in close proximity
to the primary tumor. Treatment can lead to radiation-
induced toxicity when such organs receive excessive dose.
Therefore, radiotherapy treatment planning aims to minimize
the radiation dose to the organs at risk (OARs), while deliver-
ing sufficient dose levels to the target volumes [2].
Advanced delivery techniques, such as intensity modu-
lated radiotherapy (IMRT) and Volumetric Modulated Arc
Therapy (VMAT), have led to improved radiation dose distri-
butions [3]. Doses to OARs could further be reduced by the
use of Intensity Modulated Proton Therapy (IMPT) [4]. Both
VMAT and IMPT make use of treatment beams with multiple
segments that sequentially irradiate different parts of the
CTV volume. This fragmentation creates a risk of interplay
between the tumor motion and the dose deposition [4]. This
may distort the intended dose distribution and subsequently
lead to local under- and overdosage [5]. Therefore, it is
essential to be more vigilant of tumor motion when treating
thoracic EC with advanced radiotherapy techniques.
When treating EC with radiotherapy, the surrounding
organs may influence the delivered dose to the target vol-
umes. The position of the diaphragm with respect to the
treatment beams, mainly in Inferior-Superior direction, may
have a major influence on the radiological equivalent path
lengths of these treatment beams. This is especially true of
tumors in the distal esophagus and gastroesophageal junc-
tion (GEJ).
Tumors located near the diaphragm are often highly
mobile due to respiratory motion [6,7]. Balter et al. [8]
reported that the diaphragm is an acceptable anatomical
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landmark for radiographic estimation of liver motion. The
motion of inferiorly located lung cancers correlated well with
the apex of the diaphragm [9]. The GEJ is normally located
at the level of the esophageal hiatus of the diaphragm. The
esophageal hiatus lies immediately anteriorly and slightly to
the left, and is separated from the aortic hiatus by the decus-
sation of the right crus of the diaphragm [10]. Therefore, we
assume that the left side of the diaphragm is a good ana-
tomic landmark for tumors located in the distal esophagus
or in the GEJ.
There is a substantial number of studies that report inter-
fraction variation and breathing motion in EC [1,11–23].
However, most studies only evaluate breathing amplitudes
on the planning CT-scan [12,13,15–20] while inter-fraction
variations in breathing amplitudes are not usually investi-
gated. Of those who did investigate the inter-fraction vari-
ation [1,11,14,21–23], only three studies used 4D imaging
techniques [1,11,14]. In these studies, only the end-expiration
phase was included in the inter-fractional variation analyses
or displacements were not reported with respect to the
bony anatomy, which is the current standard matching
protocol in position verification for the treatment of EC.
Therefore, the aim of the current study was to evaluate
the magnitude and inter-fractional variation of the breathing
motion and position of the diaphragm with respect to the
bony anatomy from repeat 4D CT-scans. To this end, the dia-
phragm was used as an anatomical landmark for EC.
Furthermore, we wanted to demonstrate the potential
impact of these inter-fractional variations on high precision




A total of 20 patients with histologically proven EC were
included between December 2016 and July 2017. Treatment
consisted of curative photon radiotherapy, with or without
chemotherapy, followed by surgery for most patients (80%).
This study was approved by the institutional ethics board
and all patients provided written, informed consent.
Data collection and procedures
Image acquisition
For RT-treatment planning, a 4D CT scan (pCT) (Somatom
Definition AS, 64 slice, Siemens Medical Inc.) was acquired
for each patient. In addition, 4–6 weekly repeat 4D CT-scans
(rCT) were performed, depending on the treatment schedule.
Patients were scanned head-first in a supine position with
arms above the head using an arm rest. The respiratory cycle
was monitored with the use of the Anzai gating system
(Anzai Medical Co., LTD). The CT images were reconstructed
into 10 consecutive temporal breathing phases, as well as an
average scan. The scans were imported into the treatment
planning system (Raystation, Raysearch Laboratories AB,
Stockholm, Sweden).
Diaphragm motion and location
All phases of the 4D CT-scans were evaluated to establish
the maximum expiration and inspiration phase. The dia-
phragm was delineated on the left side in all scans, since the
GEJ is situated at this side of the body [6,7]. The diaphragm
delineations on the expiration phase (DE) and the inspiration
phase (DI) were transferred to the average CT-scans. The
breathing amplitude was determined for each 4D scan by
the linear superior-inferior (SI) distance between the most
superior points of the DE and DI delineations.
To establish the location of the diaphragm with respect to
the bony anatomy, the distance from the most superior part
of the 12th thoracic vertebra (TH12) to the superior part of
the DE and DI delineations was measured in coronal view on
each pCT and rCT (Figure 1). The off-set was defined for each
4D scan by the measured difference in DE and DI diaphragm
positions on the rCTs with respect to corresponding pCTs.
The diaphragm as an anatomical landmark for EC
Based on the close anatomic relationship between the GEJ
and the left diaphragm, the diaphragm displacement was
Figure 1. Measuring the distance (red arrows) from the twelfth thoracic verte-
brae to the diaphragm delineated in the scans corresponding to the end of
inspiration (orange) and end of expiration (green) breathing phases. Distances
were measured in the superior-inferior direction. Off-sets were determined by
calculating the difference between the position of the diaphragm in the repeat
CT and the planning CT scans.
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used as a surrogate for the esophageal/GEJ target motion.
The distal part of the esophagus is subjected to shifts due to
longitudinal muscle contractions and laxity of the phrenoeso-
phageal attachments, including the periesophageal fascia
around the esophageal hiatus with the esophagus and con-
striction of the anatomic sphincter during inspiration [6,7,24].
Therefore, it can be expected that deviations in target pos-
ition occur concurrent with the observed variations in
breathing off-set and amplitude will result in variations in
the position of the gross tumor volume (GTV).
To test this hypothesis, we determined motion and base-
line shift data of the GTV from the weekly 4D CT-scans and
compared those to the diaphragm shifts. The GTV was
delineated by the treating radiation oncologist. Deformable
image registration was performed in Raystation (ANACONDA)
between the expiration phase (50%) of the pCT and the 50%
of the rCT-scans at the different timepoints. The mean and
95th percentile of the deformation vector lengths within the
GTV were determined. Furthermore, the inferior-superior
components of the vectors were determined and averaged
over the GTV volume.
Dosimetric validation
Differences in diaphragm position between the weekly
repeat CT-scans (rCTs) and planning CT-scan (pCT) may result
in large changes to the radiological equivalent path length,
resulting in relevant dose deviations [25,26]. To illustrate this,
we recalculated both a VMAT plan and an IMPT plan on rCTs
with a small and large diaphragm off-set. Thereafter, we
recalculated both VMAT plans and IMPT plans of patients
which exceed the DE off-set of >0.8 cm and DI off-set of
<0.8 cm. We assessed the voxelwise minimum and max-
imum plans as we do in general practice.
The VMAT plans as well as the IMPT plans were generated
on the average CT-scan reconstructed from the 4D-CT scan.
The same procedure was used for the dose calculations on
the repeat CT-scans. The ITV was generated by adjusting the
CTV manually to incorporate the movement of the target in
all breathing phases and the PTV by an expansion of 8mm
from this ITV. The IMPT plans were robustly optimized (using
Monte Carlo) to cover the Internal Target Volume (ITV) and
to be robust against range errors (±3%) and setup errors
(8mm) [27]. The plans contained two beams: one posterior
and one right posterior oblique field. The VMAT plans were
planned on a Planning Target Volume (PTV) margin of
0.8 cm, the current clinical margin for this patient group and
contained two 6MV arcs. All VMAT and IMPT plans were clin-
ically acceptable regarding target and OAR dose.
Statistics
To analyze the agreement in breathing motion between the
rCTs and pCTs, a mixed model analysis with random inter-
cept was performed [28]. The mixed model analysis indicates
whether the average diaphragm position with respect to the
bony anatomy, and the breathing amplitude of the pCT, is
predictive for those parameters determined from the rCTs.
Thereafter, a scatterplot was generated in SPSS Version 23.0
with the regression lines of the mixed model analysis (IBM
SPSS Statistics for Windows, Released 2015. IBM Corp,
Armonk, NY). The differences between the baseline pCT val-
ues and those determined from the rCTs are shown in Bland-
Altman plots. Also presented are the mean differences (M)




One of the 20 patients withdrew written consent after two
weeks of RT. The mean age of the 19 remaining patients was
67.9 (range 53.4–83.9) years. Dose prescriptions were 41.4/23,
50.4/28 or 51/17Gy/fractions. All baseline patient characteris-
tics are shown in Table 1.
Artifacts due to slow breathing frequencies were visible on
20 4D CT-scans, from the scans of eight patients. Scans of two
patients showed artifacts on only one rCT and these scans
were excluded from the analysis. In two patients, only the pCT
contained artifacts, therefore we used the first rCT as the ref-
erence scan. In total, four patients were excluded due to arti-
facts on both the pCT and multiple rCTs. All further analyses
were performed using data from the remaining 15 patients.
Breathing motion (amplitude)
The baseline (pCT) breathing amplitudes ranged from 0.75 to
2.20 cm with a mean amplitude (SD) of 1.12 (0.34) cm. The
baseline breathing amplitude was <1.00 cm for three patients
(20%), between 1.00 and 2.00 cm for 11 patients (73%) while
one patient (7%) had a baseline amplitude of >2.00 cm.
The amplitudes in the weekly rCTs ranged from 0.50 to
2.20 cm with a mean (SD) of 1.17 (0.41) cm. Compared to the
baseline amplitudes, the mean (SD) of the absolute ampli-
tude differences was 0.25 (0.21) cm with a range of
0.00–0.80 cm (Supplementary Figure 1(c) and Supplementary
Table 1). Of the 70 rCTs, 23 scans (32.9%) showed a decrease
in amplitude, 32 scans (45.7%) an increase, and in 15 CT-
scans (21.4%) the amplitude was similar to the baseline
measurements.
Table 1. Patient characteristics.
N %
Number of patients 19 100











Prescribed radiotherapy treatment dose
23 1.8 Gy ¼ 41.4 Gy 15 78.9
28 1.8 Gy ¼ 50.4 Gy 3 15.8
17 3.0 Gy ¼ 51.0 Gy 1 5.3
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Breathing motion relative to bony anatomy (off-set)
Off-set values of the EC relative to the thoracic vertebra,
TH12, are shown in Supplementary Figure 1(a,b) and
Supplementary Tables 2 and 3. The average off-set value was
0.51 cm (SD: 0.45 cm; range: 2.08 to 1.93 cm). The mean
absolute DI off-set was 0.57 cm (SD: 0.50 cm). A decrease in
off-set corresponds to a more caudal diaphragm position
compared to the pCT. Patients with a risk of under-dosage of
the tumor are those with a positive expiration off-set and/or
a negative inspiration off-set were the tumor moves out of
the defined target volume. From the 70 rCTs, a positive
expiration off-set was observed in 31 cases (44.3%) and a
negative inspiration off-set in 41 rCTs (58.6%).
The DE and DI off-sets extended beyond the PTV margin
of 0.8 cm in 4 (5.7%) and 13 (18.6%) rCTs, respectively.
Patients 3, 5 and 16 showed off-sets larger than the PTV
margin on multiple rCTs. In the Supplementary Figure 2,
patients’ individual DE and DI off-sets and amplitude differ-
ences are shown with respect to the 0.8 cm PTV margin.
Analysis of breathing motion and diaphragm position
The off-set values were checked for normality with the
Shapiro–Wilk test and Q-Q plots and appeared to be nor-
mally distributed (p> 0.05). The mixed model analysis
showed a pooled effect size (b (standard error)) of 0.92 (0.05)
(p< 0.01) for the DE off-set analysis and 0.91 (0.06) (p< 0.01)
for the DI off-sets. The pooled effect size of the amplitude
analysis was 0.80 (0.17) (p< 0.01). The scatterplots with the
mixed model regression lines are shown in Supplementary
Figure 3(a–c). All analyses showed that the breathing ampli-
tudes and differences in diaphragm position with respect to
the bony anatomy on the planning CT-scan were significant
predictors for the measurements in the repeat CT-scans.
The Bland-Altman plots illustrate the agreement of the DE
and DI off-sets and the breathing amplitude differences of
the repeat CT-scans with respect to the planning CT
(Figure 2(A–C)). The 95% limits of agreement (LOA) indicate
the mean off-set ± 1.96 SD. The plots showed that most
measurements are within the LOA meaning the values of the
repeat CT-scans are not significantly different from the plan-
ning CT-scans. The outliers in the amplitude and the off-set
plots correspond to different patients.
The diaphragm as an anatomical landmark for EC
The mean vector length and the 95th percentile of the vec-
tor lengths in the GTV determined from the deformation vec-
tor field show a reasonable correlation with the diaphragm
expiration off-set with a coefficient of determination R2 of




































































































































Figure 2. (A) Bland-Altman plot showing the changes with respect to the planning CT in distance of diaphragm expiration delineation to TH12 (expiration off-set).
(B) Bland-Altman plot of the inspiration off-set. (C) Bland-Altman plot showing the diaphragm amplitude differences with respect to the planning CT.
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respectively (Figure 3(A,B)). The inferior-superior component
shows a strong correlation (R2 ¼ 0.82; a¼ 0.42) with the dia-
phragm expiration off-set (Figure 3(C)).
Dosimetric validation
The VMAT and IMPT plans created for a patient with a large
off-set (2.08 cm DI and 1.68 cm DE) are shown in
Figure 4(A). Increase in dose with localized overdosage (hot-
spots) up to 119.5% of the prescribed dose occurred not
only in the target, but also in the heart region for the VMAT
plan. For the IMPT plan hotspots up to 110.8% of the pre-
scribed dose were seen. Consequently, for the IMPT plan the
mean heart dose increased from 11.3Gy on the pCT to
15.1 Gy on the rCT. For the VMAT plan it increased from
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Diaphragm expiration off-set (cm)
Figure 3. (A) Mean vector length plotted against Diaphragm expiration offset. (B) 95th percentiles of the vector lengths plotted against Diaphragm expiration off-
set. (C) Mean inferior-superior component plotted against Diaphragm expiration offset.
Figure 4. Dose distribution comparison of a VMAT plan with an IMPT plan of a patient with a large diaphragm position off-set (A) and a patient with a small dia-
phragm position off-set (B). For the VMAT plan, the PTV (dark red) and ITV (red) are shown and for the IMPT plan only the ITV (red) is shown.
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coverage with a V95 of 98.6% was observed. The VMAT and
IMPT plans for the patient exhibiting a small off-set in DE
and DI showed no relevant over- or underdosages
(Figure 4(B)).
The VMAT and IMPT plans created for patients which
exceed the DE off-set >0.8 cm and DI off-set <0.8 cm are
shown in Supplementary Figure 4. The voxelwise minimum
and maximum plans of the repeat CT-scans showed under-
dosage and large overdosage areas for the VMAT plans. The
IMPT plans showed only small areas of under
and overdosage.
Discussion
In this study, we demonstrated that patients’ diaphragm pos-
ition on rCTs differed from the pCT even when the breathing
amplitude remained stable. The established DE and DI off-
sets were relatively large and ranged from 2.08 to 1.93 cm,
(average off-set 0.5 cm).
As indicated in the introduction, the baseline breathing
motion has been evaluated in several other studies. For distal
EC, the reported mean peak-to-peak amplitudes were
between 0.35 and 1.37 cm in the superior-inferior (SI) direc-
tion (Supplementary Table 4 and Supplementary Figure 5)
[11–20]. In the current study, the baseline diaphragm ampli-
tudes appeared slightly larger than reported in literature,
ranging from 0.75 to 2.20 cm, with a mean (SD) of 1.12
(0.34) cm.
No significant differences in breathing amplitude between
pCT and rCT were observed in this study, which is consistent
with published literature. The mean DE off-set of the dia-
phragm observed was of the same order of magnitude as
that reported by J. Wang et al. (6.8mm in SI direction) for
the GEJ junction and J.Z. Wang (5.8mm in SI direction) for
the position of the IGTV [1,14]. However, Jin et al. [11] found
much smaller inter-fraction variations in trajectory shapes.
This could be explained by the fact that they determined the
variation in inspiration and expiration positions of fiducials
with respect to the trajectory centroid position of the tumor,
and not with respect to the bony anatomy, as other studies
have done.
Other differences between our study and these just men-
tioned are that J. Wang et al. and J-Z. Wang et al. defined
breathing phase 50% as the end of expiration for analysis.
We inspected all phases and took the phase where the dia-
phragm is in its most superior position, which was not
always the 50% phase. Furthermore, these studies did not
analyze the maximum inspiration phase. Not including max-
imum inspiration could result in an underestimation of the
variability. Our study revealed that DI off-set values exceeded
the PTV margin more frequently than that of DE (13 vs. 4).
Recently, Huijskens et al. [29] compared the right-sided dia-
phragm motion of 12 pediatric patients using planning 4D
CT-scans with the inspiration and expiration phases of CBCT
images. Their results suggest that reproducibility in dia-
phragm amplitude for pediatric patients is worse than that
of adults. Our study found no significant differences in adult
diaphragm amplitudes between planning and treatment. The
mean amplitudes of diaphragm motion reported by
Huijskens et al. (11.6mm in the CBCTs) corresponded well to
the amplitudes we observed.
We tested the hypothesis that variations in breathing off-
set results in variations in the position of the GTV. The results
showed good and reasonable correlation which indicates
that the GTV position is influenced by the position of the
diaphragm. The magnitude of the 95th percentile of the vec-
tor lengths is of the same order as the diaphragm expiration
offset. The mean vector length and the mean inferior-super-
ior component of the vectors are smaller. This could be
explained by diaphragm motion causing tumor motion in
the superior-inferior direction as well as the lateral and ven-
tral-dorsal direction. Furthermore, mean vector lengths are
averaged over the whole GTV volume, including the cranial
parts of the tumor that are located further away from the
diaphragm and therefore show smaller movement.
Daily changes in diaphragm and consequently in tumor
position may result in clinically relevant dose deviations. The
target can be partially missed when large off-sets occur,
especially if patient position verification is based on bony
anatomy. Bone matching is common clinical practice for
CBCT-pCT registration in most institutes. The use of fiducial
markers at the tumor borders would improve the visibility of
the target, and consequently the quality of position verifica-
tion using CBCTs [12,17]. However, Jin et al. [23] recom-
mended against using marker-based position corrections due
to the large tissue deformations that can occur in the distal
esophagus. Instead they suggest position corrections based
on bony anatomy, and using the markers to check that the
tumor is still inside the projected PTV.
The dosimetric impact of diaphragm motion was demon-
strated for two sample patients with a large and small off-set
as well as for patients which showed a DE off-set >0.8 cm
and a DI off-set <0.8 cm. For the latter group the VMAT
plans show large under- and overdosages however the sam-
ple size is too small to indicate if there is a relation between
the off-set values and the size of the dose deviations. These
results must be confirmed in larger treatment planning stud-
ies, including a full 4D evaluation (with interplay effects) of
the cumulative influence of the breathing motion on target
coverage and OAR dose for esophageal cancer patients.
Heethuis et al. [30] analyzed weekly cine-MRI scans for 20
EC patients. They observed that intra-fraction EC tumor
motion was highly variable between and within patients, and
does not only comprise breathing motion but is also caused
by tumor drift and additional deep inhalation motion by
some patients.
The risk of dose deviations due to either off-sets in
breathing motion, tumor drift or deep inhalation may be
reduced by using motion mitigation techniques, such as
breath hold techniques. In a recent study, Doi et al. [31]
investigated target motion by quantifying fiducial marker dis-
placement between different breath-holds compared to free-
breathing. They showed that the breath-hold technique is
feasible, and minimizes the esophageal cancer target dis-
placement. Other methods to minimize breathing motion are
abdominal compression or mechanical ventilation [32].
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Further study into the applicability of those methods for EC
treated with VMAT or IMPT techniques is necessary.
Conclusion
Although the amplitude of breathing motion may seem con-
sistent over the course of radiotherapy, off-set of the dia-
phragm position and consequently tumor position can be
clinically relevant. Sufficiently large off-sets can result in a
treatment that either misses the tumor location or results in
unintended under- or overdosages in localized regions for
patients treated with VMAT or IMPT plans. It is therefore
important to develop protocols for better patient stratifica-
tion toward different motion mitigation strategies, daily
motion monitoring and 4D optimized high precision
radiotherapy.
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